Literature DB >> 18947329

Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis.

Katherine A Fethers1, Christopher K Fairley, Jane S Hocking, Lyle C Gurrin, Catriona S Bradshaw.   

Abstract

We performed a systematic review and meta-analysis of the association between sexual risk factors and bacterial vaginosis (BV). Forty-three studies reported new or multiple sexual partners and condom use relative to prevalent, incident, or recurrent BV. The summary estimate of the relative risk for the association between BV new or multiple male partners was 1.6 (95% confidence interval, 1.5-1.8), between BV and any female partners was 2.0 (95% confidence interval, 1.7-2.3), and between BV and condom use was 0.8 (95% confidence interval, 0.8-0.9). This review is the first to summarize available observational data for BV. It shows that BV is significantly associated with sexual contact with new and multiple male and female partners and that decreasing the number of unprotected sexual encounters may reduce incident and recurrent infection. Investigation of sexual transmission of BV is limited by the absence of a clear microbiological etiology; however, we have shown that the epidemiological profile of BV is similar to that of established sexually transmitted infections.

Entities:  

Mesh:

Year:  2008        PMID: 18947329     DOI: 10.1086/592974

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  108 in total

1.  Emerging Sexual Health Issues Among Women Who Have Sex with Women.

Authors:  Jeanne M Marrazzo; Linda M Gorgos
Journal:  Curr Infect Dis Rep       Date:  2012-02-02       Impact factor: 3.725

2.  Prevalent Herpes Simplex Virus-2 Increases the Risk of Incident Bacterial Vaginosis in Women from South Africa.

Authors:  Nathlee S Abbai; Makandwe Nyirenda; Sarita Naidoo; Gita Ramjee
Journal:  AIDS Behav       Date:  2018-07

3.  Examining targets for HIV prevention: intravaginal practices in Urban Lusaka, Zambia.

Authors:  Maria L Alcaide; Maureen Chisembele; Miriam Mumbi; Emeria Malupande; Deborah Jones
Journal:  AIDS Patient Care STDS       Date:  2014-02-25       Impact factor: 5.078

4.  An anthropologically based model of the impact of asymptomatic cases on the spread of Neisseria gonorrhoeae.

Authors:  Ashley Hazel; Simeone Marino; Carl Simon
Journal:  J R Soc Interface       Date:  2015-05-06       Impact factor: 4.118

5.  Bacterial vaginosis and the risk of trichomonas vaginalis acquisition among HIV-1-negative women.

Authors:  Jennifer E Balkus; Barbra A Richardson; Lorna K Rabe; Taha E Taha; Nyaradzo Mgodi; Margaret Phiri Kasaro; Gita Ramjee; Irving F Hoffman; Salim S Abdool Karim
Journal:  Sex Transm Dis       Date:  2014-02       Impact factor: 2.830

Review 6.  Antibiotic treatment for the sexual partners of women with bacterial vaginosis.

Authors:  Jairo Amaya-Guio; David Andres Viveros-Carreño; Eloisa Mercedes Sierra-Barrios; Mercy Yolima Martinez-Velasquez; Carlos F Grillo-Ardila
Journal:  Cochrane Database Syst Rev       Date:  2016-10-01

7.  Risks for acquisition of bacterial vaginosis among women who report sex with women: a cohort study.

Authors:  Jeanne M Marrazzo; Katherine K Thomas; Tina L Fiedler; Kathleen Ringwood; David N Fredricks
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

Review 8.  Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation.

Authors:  Catriona S Bradshaw; Jack D Sobel
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

Review 9.  Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses.

Authors:  Christina A Muzny; Jane R Schwebke
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

10.  Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors.

Authors:  K Baisley; J Changalucha; H A Weiss; K Mugeye; D Everett; I Hambleton; P Hay; D Ross; C Tanton; T Chirwa; R Hayes; D Watson-Jones
Journal:  Sex Transm Infect       Date:  2009-05-26       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.